GDOC:NYE-Goldman Sachs ETF Trust (USD)

ETF | Others |

Last Closing

USD 34.8189

Change

-0.24 (-0.68)%

Market Cap

USD 0.02B

Volume

711.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The fund invests, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes (measured at the time of purchase) in equity investments in U.S. and non-U.S. health care companies. The adviser generally intends to invest in companies that the adviser believes are aligned with key themes associated with innovation in health care, which include, but are not limited to, genomics, precision medicine, technology-enabled procedures, and digital healthcare. The fund is non-diversified.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-07 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SOJE Southern Company (The) Series ..

-0.29 (-1.32%)

USD 65.72B
JEPI JPMorgan Equity Premium Income..

-0.31 (-0.52%)

USD 35.80B
DFAC Dimensional U.S. Core Equity 2..

-0.27 (-0.79%)

USD 31.31B
DTB DTE Energy Company 2020 Series

-0.25 (-1.18%)

USD 26.58B
JPST JPMorgan Ultra-Short Income ET..

N/A

USD 26.13B
SGOV iShares® 0-3 Month Treasury B..

+0.01 (+0.01%)

USD 25.73B
GBTC Grayscale Bitcoin Trust (BTC)

+0.76 (+1.53%)

USD 23.75B
AVUV Avantis® U.S. Small Cap Value..

-0.44 (-0.46%)

USD 13.57B
JAAA Janus Detroit Street Trust - J..

+0.02 (+0.04%)

USD 12.95B
DFUV Dimensional US Marketwide Valu..

-0.20 (-0.48%)

USD 11.37B

ETFs Containing GDOC

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.46% 44% F 49% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.46% 44% F 50% F
Trailing 12 Months  
Capital Gain 14.97% 46% F 49% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.97% 46% F 49% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 0.02B 32% F 12% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.